USE OF A PCSK9 INHIBITOR TO TREAT HYPERLIPIDEMIA

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

14511975

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides methods for treating hyperlipidemia in patients who are not on statin therapy. The methods of the present invention comprise administering to a patient a pharmaceutical composition comprising a PCSK9 inhibitor. In certain embodiments, the PCSK9 inhibitor is an anti-PCSK9 antibody such as the exemplary antibody referred to herein as mAb316P.

First Claim

See full text

Other Claims data not available

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANOFI BIOTECHNOLOGY54 RUE LA BOÉTIE PARIS 75008

International Classification(s)

loading....
  • 2014 Application Filing Year
  • A61K Class
  • 14144 Applications Filed
  • 11600 Patents Issued To-Date
  • 82.02 % Issued To-Date
Click to zoom InYear of Issuance% of Matters IssuedCumulative IssuancesYearly Issuances2014201520162017201820192020202120222023202420250255075100

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baccara-Dinet, Marie Paris, FR 10 97
Bessac, Laurence Paris, FR 22 280
Chaudhari, Umesh Bridgewater, US 16 156
Hanotin, Corinne Paris, FR 26 301
Pordy, Robert C Tarrytown, US 32 391
Sasiela, William J Tarrytown, US 31 433
Schwemmer, Gipe Daniel A Tarrytown, US 9 58

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • 21 Citation Count
  • A61K Class
  • 95.83 % this patent is cited more than
  • 10 Age
Citation count rangeNumber of patents cited in rangeNumber of patents cited in various citation count ranges4055742610302931335621135761001 - 1011 - 2021 - 3031 - 4041 - 5051 - 6061 - 7071 - 8081 - 9091 - 100100 +0500100015002000250030003500400045005000550060006500700075008000

Forward Cite Landscape

Load Citation